Makers Labs.

Makers_Labs.26 Apr 2024

Pharmaceuticals

₹

+1.40 (+0.96%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Makers Labs.

Makers Labs.

Pharmaceuticals

Makers_Labs.26 Apr 2024

₹

+1.40 (+0.96%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
22-May-2019	D	Please note that the Board has recommended a dividend of Re. 1/- per share (10%) on the equity share of the face value of Rs. 10/- each for the financial year ended 31st March, 2019.	01-Aug-2019
23-May-2018	D	The Board has recommended a dividend of Re. 1/- per share (10%) on the equity share of face value of Rs. 10/- each for the financial year ended 31st March, 2018.	26-Jul-2018
11-May-2017	D	Makers Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 11, 2017, inter alia, has recommended a dividend of Re. 1/- per share (10%) for the financial year ended March 31, 2017.	20-Jul-2017
27-May-2016	D	Makers Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2016, inter alia, has recommended a dividend of Re. 1/- per share (10%) for the financial year ended March 31, 2016. The meeting started at 11.00 a.m. and concluded at 12.10 p.m.	02-Aug-2016
29-May-2015	D	Makers Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2015, inter alia, has transacted the following: 1. The Board has recommended a dividend of Rs. 1/- per share (10%) for the financial year ended March 31, 2015.	28-Jul-2015
20-May-2011	D	Makers Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2011, inter alia, has recommended a divided of Re. 1/- per share (10%) for the financial year ended March 31, 2011.	29-Jul-2011
31-May-2010	D	Makers Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 31, 2010, inter alia, has recommended a divided of Re. 1/- per share (10%) for the financial year ended March 31, 2010.	17-Aug-2010
29-Mar-2022	R	1:5 Rights Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Makers Laboratories Ltd has fixed Record date for the purpose of Rights Issue of Equity Shares. The transactions in the equity shares of the Company should be done on ex-rights basis with effect from the under mentioned date : DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Makers Laboratories Ltd. (506919) RECORD DATE 01.04.2022 PURPOSE Issue of 01 (One) equity shares of Rs. 10/- each for cash at a premium of Rs. 140/- on rights basis for every 05 (Five) equity shares held. Ex-Right basis from Date & Sett. No. 30/03/2022 DR-001/2022-2023 Note: Entire Rs.150/- payable on application. Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 29.03.2022) Arihant Capital Markets Ltd ('Lead Manager to the Issue') has submitted to BSE a copy of Issue Opening advertisement with regard to the Rights Issue of equity shares of Makers Laboratories Ltd ('the Company'). (As Per BSE Announcement Dated 11.04.2022)	01-Apr-2022	1:5
15-Feb-2024	BC	Resignation of Company Secretary /Compliance Officer / Key Managerial Personnel	13-Mar-2024
14-Aug-2023	BC	Proceedings of the 38th Annual General Meeting Re-appointment of Mr. R K P Verma as Independent Director and Re-appointment of Mr. Saahil Parikh as Whole-time Director	13-Feb-2024
22-Jan-2024	BC	MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Prior Intimation of the Board Meeting	13-Feb-2024
19-Oct-2023	BC	MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve unaudited financial results for Q2 an	07-Nov-2023
11-Jul-2023	BC	Annual Report 2022-23 38th Annual General Meeting to be held on Monday, 14th August, 2023 (As Per BSE Announcement dated on 12.07.2023) Proceedings of the 38th Annual General Meeting Re-app	14-Aug-2023

Announcement Date22-May-2019

Ex Dividend Date01-Aug-2019

Dividend(%)10

Announcement Date23-May-2018

Ex Dividend Date26-Jul-2018

Dividend(%)10

Announcement Date11-May-2017

Ex Dividend Date20-Jul-2017

Dividend(%)10

Announcement Date27-May-2016

Ex Dividend Date02-Aug-2016

Dividend(%)10

Announcement Date29-May-2015

Ex Dividend Date28-Jul-2015

Dividend(%)10

Announcement Date20-May-2011

Ex Dividend Date29-Jul-2011

Dividend(%)10

Announcement Date31-May-2010

Ex Dividend Date17-Aug-2010

Dividend(%)10

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)140

Ratio1:5

Book Closure

Record Date	Split Date	Purpose
13-Mar-2024	-	Resignation of Company Secretary /Compliance Officer / Key Managerial Personnel
13-Feb-2024	-	Proceedings of the 38th Annual General Meeting Re-appointment of Mr. R K P Verma as Independent Director and Re-appointment of Mr. Saahil Parikh as Whole-time Director
13-Feb-2024	-	MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Prior Intimation of the Board Meeting
07-Nov-2023	-	MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve unaudited financial results for Q2 an
14-Aug-2023	-	Annual Report 2022-23 38th Annual General Meeting to be held on Monday, 14th August, 2023 (As Per BSE Announcement dated on 12.07.2023) Proceedings of the 38th Annual General Meeting Re-app

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Makers Laboratories Ltd ₹147.30(+1.40/0.96%)	147.30	+1.40	86.91	33.71	0.00	1.59
Astrazeneca Pharma India Ltd ₹5,415.40(+81.55/1.53%)	5,415.40	+81.55	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹122.60(+5.85/5.01%)	122.60	+5.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,409.40(+4.00/0.28%)	1,409.40	+4.00	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,864.85(+201.35/0.78%)	25,864.85	+201.35	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹680.85(-8.80/-1.28%)	680.85	-8.80	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	11.17	14.92	11.54	10.84	10.63	11.41
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	11.17	14.92	11.54	10.84	10.63	11.41
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.12	0.69	0.19	0.18	0.14	0.69
Total Income	11.29	15.62	11.73	11.02	10.76	12.10
Total Expenditure	12.28	15.64	13.33	11.02	12.47	12.00
PBIDT	-0.99	-0.03	-1.60	0.00	-1.71	0.10
Interest	0.42	0.41	0.35	0.28	0.40	0.33
PBDT	-1.41	-0.43	-1.94	-0.28	-2.11	-0.23
Depreciation	0.68	0.68	0.67	0.66	0.66	0.60
Tax	0.00	0.00	0.00	0.02	0.00	0.00
Deferred Tax	-0.15	-0.12	-0.15	-0.14	-0.21	-0.11
Reported Profit After Tax	-1.95	-0.99	-2.46	-0.80	-2.57	-0.71
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-1.95	-0.99	-2.46	-0.80	-2.57	-0.71

EPS (Unit Curr.)	-3.30	-1.68	-4.17	-1.29	-4.25	-1.07
EPS (Adj) (Unit Curr.)	-3.30	-1.68	-4.17	-1.29	-4.25	-1.07
Calculated EPS (Unit Curr.)	-3.30	-1.68	-4.17	-1.36	-4.36	-1.21
Calculated EPS (Adj) (Unit Curr.)	-3.30	-1.68	-4.17	-1.36	-4.36	-1.21
Calculated EPS (Ann.) (Unit Curr.)	-13.19	-6.71	-16.68	-5.46	-17.42	-4.83
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-13.19	-6.71	-16.68	-5.46	-17.42	-4.83
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	5.90	5.90	5.90	5.90	5.90	5.90
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-8.86	-0.20	-13.86	0.00	-16.09	0.88
PBDTM(%)	-12.62	-2.88	-16.81	-2.58	-19.85	-2.02
PATM(%)	-17.46	-6.64	-21.32	-7.38	-24.18	-6.22

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	26.51	25.06	25.01	29.45	19.88	26.50
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	26.51	25.06	25.01	29.45	19.88	26.50
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.37	0.41	0.33	0.12	0.27	0.88
Total Income	26.88	25.47	25.33	29.57	20.14	27.38
Total Expenditure	26.31	24.86	25.21	27.67	20.05	24.88
PBIDT	0.57	0.61	0.12	1.90	0.09	2.51
Interest	0.53	0.49	0.41	0.25	0.42	1.07
PBDT	0.04	0.12	-0.30	1.66	-0.33	1.44
Depreciation	1.16	1.13	1.11	1.13	1.19	1.03
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.19	0.19	0.39	0.33	0.42	0.45
Deferred Tax	-0.24	-0.08	-0.13	-0.15	-0.16	-0.11
Reported Profit After Tax	-1.06	-1.13	-1.66	0.35	-1.77	0.07
Minority Interest After NP	0.48	0.21	0.44	0.63	0.43	0.71
Net Profit after Minority Interest	-1.54	-1.34	-2.10	-0.28	-2.21	-0.64

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-1.54	-1.34	-2.10	-0.28	-2.21	-0.64

EPS (Unit Curr.)	-2.61	-2.27	-3.55	-0.43	-3.65	-1.00
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	5.90	5.90	5.90	5.90	5.90	5.90

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	2.15	2.43	0.48	6.45	0.45	9.47
PBDTM(%)	0.15	0.48	-1.20	5.64	-1.66	5.43
PATM(%)	-4.00	-4.51	-6.64	1.19	-8.90	0.26

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	5.90	4.92	4.92	4.92	4.92	4.92
Reserves Total	52.38	45.38	44.70	39.70	36.78	31.90
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	58.28	50.30	49.62	44.62	41.70	36.82
Secured Loans	9.24	8.30	11.20	10.69	6.38	1.29
Unsecured Loans	1.96	11.10	4.79	2.36	0.00	0.00
Total Debt	11.20	19.40	15.99	13.05	6.38	1.29
Total Liabilities	69.48	69.70	65.61	57.67	48.08	38.11
APPLICATION OF FUNDS :
Gross Block	54.10	41.74	40.73	38.83	22.09	19.14
Less : Accumulated Depreciation	13.65	11.81	10.14	5.95	3.99	2.52
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	40.45	29.93	30.59	32.88	18.10	16.62
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.04	8.94	0.12	0.69	6.42	0.11
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	22.52	22.55	23.66	15.04	11.16	9.18
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	8.20	12.19	10.89	10.69	11.65	13.35
Sundry Debtors	7.53	5.35	7.19	7.55	5.02	11.22
Cash and Bank	0.08	0.14	0.34	0.96	2.25	0.23
Loans and Advances	3.36	3.67	4.78	4.56	3.88	1.85
Total Current Assets	19.16	21.35	23.20	23.76	22.79	26.64
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	12.30	13.28	11.05	12.65	9.39	13.18
Provisions	1.61	1.67	1.76	1.69	1.49	1.08
Total Current Liabilities	13.90	14.95	12.81	14.35	10.88	14.25
Net Current Assets	5.25	6.40	10.39	9.42	11.91	12.39
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1.81	0.20	0.12	0.50	0.08	0.09
Deferred Tax Liability	2.00	0.83	0.60	2.17	0.96	0.83
Net Deferred Tax	-0.19	-0.63	-0.48	-1.67	-0.88	-0.74
Total Assets	68.07	67.20	64.28	56.36	46.71	37.55
Contingent Liabilities	1.85	1.48	1.33	1.70	0.88	0.99

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.05	0.26	0.87	2.16	1.16
Net Cash from Operating Activities	-1.42	6.80	0.67	4.23	5.39
Net Cash Used In Investing Activities	-3.55	-8.78	-2.65	-8.43	-8.31
Net Cash Used In Financing Activities	4.94	1.77	1.37	2.91	3.92
Net Inc./Dec In Cash And Cash Equivalents	-0.04	-0.21	-0.61	-1.29	1.00
Cash And Cash Equivalents At End Of The Year	0.01	0.05	0.26	0.87	2.16

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

61.27%

FII Shareholding

0.00%

DII Shareholding

0.39%

Public Shareholding

38.34%

**Promoter pledged shareholding 61.27%

About Makers Laboratories Ltd

Makers Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 86.91 crores. It has reported a sales of Rs. 11.17 crores and a net profit of Rs. -1.95 crores for the quarter ended December 2018. The company management includes R K P Verma, R K P Verma,Dipti Shah,Vishal Jain,Prashant Godha,Saahil U Parikh,Nilesh Jain,Surbhi Sharma (Makers Laboratories Ltd) among others.

Chairman

R K P Verma

Registered office

54 D Kandivli Industrial Estat,Charkop Kandivli (West),Mumbai,Maharashtra,400067

FAX :91-22-2868 8544

Background

Incorporation Year1984

Face Value₹10

Market Lot1

How to buy Makers Labs. shares on nse?

To buy Makers Labs. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Makers Labs. share price today?

The Makers Labs. shares price on nse is Rs.147.3 today.

What is the market cap of Makers Labs. shares on BSE ?

The company has a market capitalization of Rs.86.91Cr

What is the PE & PB ratio of Makers Labs. shares ?

PE is 0 and PB is 1.59

What is the 52 Week High and Low of Makers Labs. shares?

Makers Labs. stock price high: Rs.157 Makers Labs. stock price low: Rs.94